BLOG/🇺🇸United States··daily

S&P 500 Healthcare Sector SEC Filings — January 04, 2026

USA S&P 500 Healthcare

10 high priority14 medium priority24 total filings analysed

Executive Summary

Across 24 8-K filings on January 5, 2026, in the USA S&P 500 Healthcare stream, activity is overwhelmingly neutral with low materiality, dominated by vague Item 8.01 disclosures and lacking quantitative details, though many originate from non-healthcare firms suggesting potential data filtering noise. Healthcare-specific signals are sparse but critical: bearish delisting risk in biotech (Protagenic Therapeutics) and neutral Reg FD from S&P 500 constituent Moderna, amid patterns of leadership changes and material agreements elsewhere. Cumulative impact on the healthcare sector remains minimal, with no evident cross-filing correlations driving broad trends, implying a quiet day for institutional positioning.

Tracking the trend? Catch up on the prior S&P 500 Healthcare Sector SEC Filings digest from January 01, 2026.

Investment Signals(4)

  • Protagenic Therapeutics delisting notice and failure to meet listing standards [BEARISH] - Protagenic Therapeutics

  • UMeWorld Inc. change in certifying accountant signaling potential reporting issues [BEARISH] - UMeWorld Inc.

  • iSpecimen Inc. entry into material definitive agreement [BULLISH] - iSpecimen Inc.

  • Moderna Reg FD disclosure potentially previewing updates [NEUTRAL-WATCH] - Moderna, Inc.

Risk Flags(4)

  • Biotech delisting risk highlighting compliance failures in smaller healthcare innovators [Protagenic Therapeutics]

  • Auditor changes indicating possible accounting or control weaknesses [UMeWorld Inc.]

  • Recurrent leadership churn across filings (e.g., Zeo ScientifiX, Six Flags, Tectonic Financial) signaling governance instability

  • Undisclosed details in multiple material agreements and Reg FD filings amplifying uncertainty

Opportunities(3)

  • Probe iSpecimen's material definitive agreement for accretive healthcare data partnerships or M&A alpha

  • Monitor Moderna's Reg FD exhibits for pipeline advancements or financial guidance in biotech/pharma

  • Assess Jade Biosciences' results of operations for undervalued biotech turnaround potential

Sector Themes(3)

  • Sparse healthcare signals amid non-sector noise

    distress in small-cap biotech (delisting) contrasts routine disclosures from leaders like Moderna

  • Prevalent vagueness in Item 8.01/9.01 filings across sectors limits transparency, with healthcare showing neutral financial updates (e.g., Jade Bio)

  • Emerging pattern of material agreements and leadership shifts hinting at consolidation prep, though not healthcare-concentrated

Watch List(4)

  • 👁

    Protagenic Therapeutics - Delisting trajectory and potential OTC transfer impacts

  • 👁

    iSpecimen Inc. (two filings) - Agreement details and other events for strategic fit in healthcare specimens

  • 👁

    Moderna, Inc. - Reg FD content for material non-public info on vaccines or R&D

  • 👁

    UMeWorld Inc. - Auditor change rationale amid high uncertainty

Filing Analyses(24)
NEWS CORP8-Kneutralmateriality 2/10

05-01-2026

News Corp filed a Form 8-K on January 5, 2026 (AccNo: 0001564708-26-000002, Size: 401 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No core event, transaction details, financial metrics, or named entities beyond the filer are specified. Sector not specified.

UMeWorld Inc.8-Kbearishmateriality 8/10

05-01-2026

UMeWorld Inc. filed an 8-K on January 05, 2026 (AccNo: 0001477932-26-000016, Size: 141 KB), reporting changes in its certifying accountant under Item 4.01. The filing also includes financial statements and exhibits under Item 9.01. No additional details on the accountant change, reasons, financial metrics, or transaction values are disclosed.

Artificial Intelligence Technology Solutions Inc.8-Kneutralmateriality 2/10

05-01-2026

Artificial Intelligence Technology Solutions Inc. filed a Form 8-K on January 05, 2026 (AccNo: 0001493152-26-000223, Size: 227 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No details on the specific events, transactions, financial statements, or exhibits are provided in the filing summary. Sector is not specified.

Zeo ScientifiX, Inc.8-Kneutralmateriality 3/10

05-01-2026

Zeo ScientifiX, Inc. filed an 8-K on January 5, 2026 (AccNo: 0001829126-26-000029, Size: 183 KB) disclosing information under Item 5.02 regarding departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on positions affected, individuals involved, reasons for change, or any quantitative data are stated. Sector not specified.

Corebridge Financial, Inc.8-Kneutralmateriality 5/10

05-01-2026

Corebridge Financial, Inc. filed a Form 8-K on January 05, 2026 (AccNo: 0001889539-26-000003, Size: 211 KB), reporting Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No details on the content of the disclosure or exhibits are provided. Sector not specified.

Beneficient8-Kneutralmateriality 1/10

05-01-2026

Beneficient filed a Form 8-K on January 05, 2026 (AccNo: 0001493152-26-000259, Size: 298 KB), reporting Items 7.01 (Regulation FD Disclosure), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). No details on the core events, transactions, financial statements, or exhibits are disclosed in the provided filing summary. Sector is not specified.

Jade Biosciences, Inc.8-Kneutralmateriality 5/10

05-01-2026

Jade Biosciences, Inc. filed a Form 8-K on January 05, 2026 (AccNo: 0001193125-26-001502, Size: 193 KB) under Items 2.02 (Results of Operations and Financial Condition), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits). This is a multi-item financial results disclosure from the US market with sector not specified. No specific financial metrics, transaction values, or quantitative data are mentioned.

Protagenic Therapeutics, Inc.new8-Kbearishmateriality 9/10

05-01-2026

Protagenic Therapeutics, Inc. filed a Form 8-K on January 05, 2026 (AccNo: 0001493152-26-000263, Size: 256 KB) disclosing under Item 3.01 a Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. Event Type: Delisting from the US market. Sector not specified; no financial details, transaction values, or other quantitative metrics disclosed.

COMMERCIAL METALS Co8-Kneutralmateriality 2/10

05-01-2026

Commercial Metals Co filed an 8-K on January 5, 2026 (AccNo: 0000022444-26-000003, size 155 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the event, transaction, financial statements, or exhibits are provided in the filing summary. Sector not specified.

Earth Science Tech, Inc.8-Kneutralmateriality 2/10

05-01-2026

Earth Science Tech, Inc. filed a Form 8-K on January 05, 2026 (AccNo: 0001493152-26-000282, Size: 237 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the other event, financial statements, or exhibits are disclosed in the provided filing summary. Sector is not specified.

Moderna, Inc.8-Kneutralmateriality 7/10

05-01-2026

Moderna, Inc. filed a Form 8-K on January 05, 2026 (AccNo: 0001682852-26-000003, Size: 238 KB), reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. This is a general filing from the US SEC with sector not specified. No details on the core event, financial statements, exhibits, or any quantitative data are disclosed in the provided information.

Lucid Group, Inc.8-Kneutralmateriality 6/10

05-01-2026

Lucid Group, Inc. filed a Form 8-K on January 05, 2026 (AccNo: 0001628280-26-000236, Size: 160 KB), reporting Results of Operations and Financial Condition under Item 2.02 and Financial Statements and Exhibits under Item 9.01. No specific financial metrics, transaction values, revenue, earnings, or other quantitative data are disclosed in the provided filing summary. This is a multi-item filing focused on financial results disclosure.

NORWOOD FINANCIAL CORP8-Kneutralmateriality 4/10

05-01-2026

Norwood Financial Corp filed an 8-K on January 5, 2026 (AccNo: 0001193125-26-001612, Size: 220 KB) announcing completion of an acquisition or disposition of assets under Item 2.01. The filing also covers departure/election of directors/officers and compensatory arrangements (Item 5.02), Regulation FD disclosure (Item 7.01), other events (Item 8.01), and financial statements/exhibits (Item 9.01). No details on parties, deal structure, valuation, or financial metrics are disclosed.

PNC FINANCIAL SERVICES GROUP, INC.8-Kneutralmateriality 5/10

05-01-2026

PNC Financial Services Group, Inc. filed a Form 8-K on January 5, 2026 (AccNo: 0000713676-26-000003, Size: 5 MB), reporting under Items 3.03 (Material Modifications to Rights of Security Holders), 5.03 (Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits). This is a multi-item filing with no specific details on the core event, transaction values, or financial impacts disclosed in the provided summary. All quantitative data and event specifics are NOT_DISCLOSED.

FLUSHING FINANCIAL CORP8-Kneutralmateriality 7/10

05-01-2026

Flushing Financial Corp filed Form 8-K on January 05, 2026 (AccNo: 0001193125-26-002449, Size: 1 MB), reporting entry into a material definitive agreement under Item 1.01, departure/election/appointment of directors/officers or compensatory arrangements under Item 5.02, and financial statements/exhibits under Item 9.01. This is a multi-item mandatory disclosure with no specific details provided on the agreement, personnel, transaction value, or financial impacts. All quantitative metrics such as dollar values, share counts, or percentages are NOT_DISCLOSED.

OCEANFIRST FINANCIAL CORP8-Kneutralmateriality 6/10

05-01-2026

OceanFirst Financial Corp filed a Form 8-K on January 5, 2026 (AccNo: 0001193125-26-002442, Size: 1 MB), reporting entry into a material definitive agreement under Item 1.01, unregistered sales of equity securities under Item 3.02, and financial statements and exhibits under Item 9.01. This is a multi-item filing with no specific details on transaction value, parties, share counts, or financial impacts disclosed in the provided summary. Sector is not specified.

Six Flags Entertainment Corporation/NEW8-Kneutralmateriality 4/10

05-01-2026

Six Flags Entertainment Corporation/NEW filed a Form 8-K on January 5, 2026 (AccNo: 0001193125-26-002477, Size: 134 KB) under Item 5.02 disclosing an officer change involving departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements. No specific details on the affected position, individual names, appointment/resignation type, reasons, or financial terms are provided in the available information. Sector is not specified.

iSpecimen Inc.8-Kneutralmateriality 7/10

05-01-2026

iSpecimen Inc. filed an 8-K on January 5, 2026 (AccNo: 0001213900-26-001257, size 263 KB), reporting entry into a Material Definitive Agreement under Item 1.01 and including Financial Statements and Exhibits under Item 9.01. No specific details on the agreement, transaction value, counterparties, or financial impacts are disclosed in the provided filing summary. Sector not specified.

SMARTFINANCIAL INC.8-Kneutralmateriality 3/10

05-01-2026

SMARTFINANCIAL INC. filed a Form 8-K on January 05, 2026 (AccNo: 0001104659-26-000697, Size: 183 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the other events or attached financial statements/exhibits are disclosed in the provided filing summary. All transaction values, financial metrics, and quantitative data are NOT_DISCLOSED.

iSpecimen Inc.8-Kneutralmateriality 2/10

05-01-2026

iSpecimen Inc. filed a Form 8-K on January 5, 2026 (AccNo: 0001213900-26-001264, Size: 188 KB) reporting under Item 8.01 Other Events. No specific details on the event, transaction, financial impacts, or other quantitative data are disclosed in the provided filing summary. Sector is not specified.

Investview, Inc.8-Kneutralmateriality 1/10

05-01-2026

Investview, Inc. filed a Form 8-K on January 5, 2026, under Item 8.01 Other Events. Accession number: 0001493152-26-000446; file size: 209 KB. No details on the specific event, transaction, financial impacts, or other quantitative data are disclosed.

Six Flags Entertainment Corporation/NEW8-Kneutralmateriality 0/10

05-01-2026

Six Flags Entertainment Corporation filed a Form 8-K on January 05, 2026, under Item 8.01 Other Events. Accession Number: 0001193125-26-002779, file size 133 KB. No details on the specific event, transaction, or financial impacts are disclosed in the provided filing summary.

Tectonic Financial, Inc.8-Kneutralmateriality 4/10

05-01-2026

Tectonic Financial, Inc. filed an 8-K on January 5, 2026 (AccNo: 0001185185-26-000029, Size: 205 KB) announcing completion of an acquisition or disposition of assets under Item 2.01. The filing also covers departure/election of directors/officers and compensatory arrangements under Item 5.02, other events under Item 8.01, and financial statements/exhibits under Item 9.01. No specific details on parties, deal structure, valuation, or financial metrics are disclosed.

Tri-County Financial Group, Inc.8-Kneutralmateriality 2/10

05-01-2026

Tri-County Financial Group, Inc. disclosed an officer change via Form 8-K filed on January 05, 2026 (AccNo: 0001493152-26-000444, Size: 457 KB). Item 5.02 covers Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. Item 9.01 includes Financial Statements and Exhibits.

Get daily alerts with 4 investment signals, 4 risk alerts, 3 opportunities and full AI analysis of all 24 filings

🇺🇸 More from United States

View all →